Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00259727 · ClinicalTrials.gov registry record
The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 80
- Enrollment target
NCT00259727 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 80 participants.
The verdict
NCT00259727 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the mechanisms by which HIV protease inhibitors contribute to the development of diabetes in HIV-infected patients. The investigators propose that some HIV protease inhibitors impair insulin secretion and increase the production of glucose by the liver.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00259727
The ClinicalTrials.gov registry entry for NCT00259727 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00259727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00259727 about?
NCT00259727 is a clinical study titled "The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism". The purpose of this study is to determine the mechanisms by which HIV protease inhibitors contribute to the development of diabetes in HIV-infected patients. The investigators propose that some HIV protease inhibitors impair insulin secretion and increase the production of glucose by the liver.
What is the current status of trial NCT00259727?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2006-01. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00259727?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.